Nuvation Bio Inc.·4

Mar 3, 8:03 PM ET

Makunje Moses 4

4 · Nuvation Bio Inc. · Filed Mar 3, 2026

Insider Transaction Report

Form 4
Period: 2026-02-27
Makunje Moses
SEE REMARKS
Transactions
  • Award

    Class A Common Stock

    [F1][F2]
    2026-02-27+50,76168,137 total
  • Award

    Stock Option (Right to Buy)

    [F3]
    2026-02-27+224,439224,439 total
    Exercise: $5.91Exp: 2036-02-26Class A Common Stock (224,439 underlying)
Footnotes (3)
  • [F1]Represents the grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of Class A Common Stock upon settlement. 25% of the shares subject to the RSUs shall vest on the Issuer's quarterly vesting date following each of the first four anniversaries from 2/27/2026, subject to Reporting Person's continuous service on each such vesting date.
  • [F2]Includes 1,001 shares acquired on May 19, 2025 and 1,100 shares acquired November 19, 2025 under the 2021 Employee Stock Purchase Plan.
  • [F3]Option vests as to 25% on the one year anniversary of 2/27/26, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.
Signature
/s/ Stephen Dang, Attorney-in-Fact|2026-03-03

Documents

2 files